![](/img/cover-not-exists.png)
Preclinical Pharmacokinetics and Safety of Sym004: A Synergistic Antibody Mixture Directed against Epidermal Growth Factor Receptor
Skartved, N. J. O., Jacobsen, H. J., Pedersen, M. W., Jensen, P. F., Sen, J. W., Jorgensen, T. K., Hey, A., Kragh, M.Volume:
17
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-11-1209
Date:
September, 2011
File:
PDF, 394 KB
english, 2011